Mometasone furoate-loaded cold processed oil-in-water emulsions: in vitro and in vivo studies

References

• Ahluwalia A. (1998). Topical glucocorticoids and the skin–mechanisms of action: an update. Mediat Inflamm 7:183–93
   PubMed Web of Science ®Google Scholar
• Arellano A, Santoyo S, Martın C, Ygartua P. (1998). Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur J Pharm Sci 7:129–35
   Web of Science ®Google Scholar
• Banga A, Bose S, Ghosh T. (1999). Iontophoresis and electroporation: comparison and contrasts. Int J Pharm 179:1–19
   PubMed Web of Science ®Google Scholar
• Berardesca E; The EEMCO Group. (1997). EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol 3:126–32
   PubMedGoogle Scholar
• Bucks D. (1984). Skin structure and metabolism: relevance to the design of cutaneous therapeutics. Pharm Res 1:148–53
   PubMedGoogle Scholar
• Carneiro R, Salgado A, Raposo S, et al. (2011). Topical emulsions containing ceramides: effects on the skin barrier function and anti-inflammatory properties. Eur J Lipid Sci Technol 133:961–6
   Google Scholar
• Cadete A, Figueiredo L, Lopes R, et al. (2012). Development and characterization of a new plasmid delivery system based on chitosan–sodium deoxycholate nanoparticles. Eur J Pharm Sci 45:451–8
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663:61–73
   PubMed Web of Science ®Google Scholar
• Clares B, Gallardo V, Medina MM, Ruiz MA. (2009). Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization. J Liposome Res 19:197–206
   PubMed Web of Science ®Google Scholar
• Coderch L, De Pera M, Fonollosa J, et al. (2002). Efficacy of stratum corneum lipid supplementation on human skin. Contact Dermatitis 47:139–46
   PubMed Web of Science ®Google Scholar
• CPMP/ICH/381/95. (2005). GUIDELINE ICH. Q2 (R1), validation of analytical procedures: text and methodology. EU: Adopted by CPMP, November 94, 2–15
   Google Scholar
• Davis AF, Hadgraft J. (1991). Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int J Pharm 76:1–8
   Web of Science ®Google Scholar
• Doktorovová S, Araújo J, Garcia ML, et al. (2010). Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B 75:538–42
   PubMed Web of Science ®Google Scholar
• Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate. 2004. Int J Toxicol 23:55–94
   Google Scholar
• Fini A, Bergamante V, Ceschel G, et al. (2008). Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. Pharm Sci Tech 9:762–8
   Web of Science ®Google Scholar
• Förster M, Bolzinger MA, Fessi H, Briançon S. (2009). Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur J Dermatol 19:309–23
   PubMed Web of Science ®Google Scholar
• Goodman M, Barry BW. (1989). Lipid–protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique. Int J Pharm 57:29–40
   Web of Science ®Google Scholar
• Jung T, Stingl G. (2008). Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 122:1074–81
   PubMed Web of Science ®Google Scholar
• Katz M, Poulsen B. (1972). Corticoid, Vehicle, and skin interaction in percutaneous absorption. J Soc Cosmet Chem 23:565–90
   Web of Science ®Google Scholar
• Kerscher M, Williams S, Lehmann P. (1991). Topical treatment with glucocorticoids. In: Ruzicka T, Ring J, Przybilla B, eds. Handbook of atopic eczema. Berlin: Springer-Verlag, 483–4
   Google Scholar
• Kraft N, Lynde C. (2005). Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett 10:1–8
   PubMedGoogle Scholar
• Lane M, Santos P, Watkinson AC, Hadgraft J. (2012). Pasive skin permeation enhancement. In: Benson H, Watkinson AC, eds. Transdermal and topical drug delivery. Principles and practice. New Jersey: Wiley, 35–7
   Google Scholar
• Lodén M. (2003). Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 4:771–8
   PubMed Web of Science ®Google Scholar
• Lopes R, Eleutério CV, Gonçalves LM, et al. (2012). Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci 45:442–50
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Koskinen LD. (2000). In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int J Pharm 195:55–62
   PubMed Web of Science ®Google Scholar
• Maia CS, Mehnert W, Schaller M, et al. (2002). Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489–95
   PubMed Web of Science ®Google Scholar
• Mao-Qiang M, Brown B, Wu-Pong S, et al. (1995). Exogenous nonphysiologic vs physiologic lipids divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 131:809–16
   PubMed Web of Science ®Google Scholar
• Miller II, Rao KJ, Goodwin YH, et al. (1993). Solubility and in vitro percutaneous absorption of tetracaine from solvents of propylene glycol and saline. Int J Pharm 98:101–11
   Google Scholar
• Mometasone Furoate Micronized ASMF, Drug master file, Crystal Pharma, 2006
   Google Scholar
• OECD. (2004). Guidance document for the conduct of skin absorption studies. Paris: OECD
   Google Scholar
• OECD Test No. 439. (2010). In vitro skin irritation: reconstructed Human epidermis test method, OECD guidelines for the testing of chemicals 1:1–18
   Google Scholar
• Potts RO, Guy RH. (1992). Predicting skin permeability. Pharm Res 9:663–9
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2000). Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 193:231–7
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 212:213–21
   PubMed Web of Science ®Google Scholar
• Raposo S, Ribeiro HM. (2011). Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios in Portuguese Patents, PT 105982, Portugal
   Google Scholar
• Raposo S, Simões S, Almeida AJ, Ribeiro HM. (2013a). Advanced systems for glucocorticoids dermal delivery. Expet Opin Drug Deliv 10:857–77
   PubMed Web of Science ®Google Scholar
• Raposo S, Salgado A, Eccleston G, et al. (2013b). Cold processed oil-in-water emulsions for dermatological purpose: formulation design and structure analysis. Pharm Dev Technol 19:417--29
   PubMed Web of Science ®Google Scholar
• Selzer D, Abdel-Mottaleb MA, Hahn T, et al. (2013). Finite and infinite dosing: difficulties in measurements, evaluations and predictions. Adv Drug Deliv Rev 65:278–94
   PubMed Web of Science ®Google Scholar
• Shah V, Besancon L, Stolk P, et al. (2010). The Pharmaceutical Sciences in 2020: report of a conference organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP). Pharmaceut Res 27:396–9
   PubMed Web of Science ®Google Scholar
• Teng X, Cutler D, Davies N. (2003). Degradation kinetics of mometasone furoate in aqueous systems. Int J Pharm 259:129–41
   PubMed Web of Science ®Google Scholar
• Tsai JC, Lu C, Lin M, et al. (2012). Effects of sebum on drug transport across the human stratum corneum in vivo. Skin Pharmacol Physiol 25:124–32
   PubMed Web of Science ®Google Scholar
• Valotis A, Neukam K, Elert O, Högger P. (2004). Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate. J Pharm Sci 3:1337–50
   Google Scholar
• VCCLAB. (2005). Virtual Computational Chemistry Laboratory, Available from: http://www.vcclab.org. [last accessed on 10 May 2013]
   Google Scholar
• Vickers CF. (1963). Existence of reservoir in the SC. Arch Dermatol 88:20–3
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Leopold CS, Guy RH. (2008). Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopham 68:453–66
   PubMed Web of Science ®Google Scholar
• Young JM, De Young LM. (1989). Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. In: Spector J, Back N, Liss AR, eds. Pharmacological methods in the control of inflammation. New York: Alan R. Liss, Inc., 215–31
   Google Scholar
• Zhang J, Smith E. (2011). Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J Pharm Sci 100:896–903
   PubMed Web of Science ®Google Scholar